VICENTE BENAVIDEZ: Open Payments
NPI 1356615421 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,389 in 130 payments from 26 companies in 2025. Trend: 2023 $2,518 · 2024 $3,441 · 2025 $2,389
Food & beverage: $2,389
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 47 | $563 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $260 |
| Novo Nordisk Inc | 16 | $214 |
| Teva Pharmaceuticals USA, Inc. | 7 | $196 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| Corcept Therapeutics | 4 | $187 |
| PFIZER INC. | 5 | $93 |
| Lilly USA, LLC | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
Products named: TEZSPIRE, CAPLYTA, UZEDY, Korlym, OTEZLA, REXULTI, Ozempic, BREZTRI.
Industry payments across CA — which companies pay providers there.
